In the BioHarmony Drug Report Database

"Preview" Icon

Hydralazine

Apresoline (hydralazine) is a small molecule pharmaceutical. Hydralazine was first approved as Apresoline on 1982-01-01. It is used to treat heart failure, malignant hypertension, and pulmonary hypertension in the USA.

 

Trade Name

 

Apresoline
 

Common Name

 

hydralazine
 

ChEMBL ID

 

CHEMBL276832
 

Indication

 

heart failure, malignant hypertension, pulmonary hypertension
 

Drug Class

 

Antihypertensives (hydrazine-phthalazines)

Image (chem structure or protein)

Hydralazine structure rendering